120
Participants
Start Date
March 20, 2022
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Deferoxamine
"There will be 3 doses given to the patients days 1-3. Dose will be given intravenous with a fixed rate of 7.5 milligram per kilogram per hour (mg/kg/hr). The second dose will be given 24 hours after the first dose, and the third dose will be given 48 hours after the initial dose.~Patients will be randomized to 32 mg/kg or 48 mg/kg of Deferoxamine."
Placebo
There will be 3 doses given to the patients days 1-3. Dose will be given intravenous with a fixed rate of 7.5 mg/kg/hr. The second dose will be given 24 hours after the first dose, and the third dose will be given 48 hours after the initial dose.
RECRUITING
University of Michigan, Ann Arbor
NOT_YET_RECRUITING
Peking University Health Science Center, Beijing
Michigan Medicine PKUHSC Joint Institute for Translational & Clinical Research
UNKNOWN
Aditya S. Pandey, MD
OTHER